Cubist Systematic Strategies, LLC Zoetis Inc. Call Options Transaction History

Cubist Systematic Strategies, LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 14, 2024	BUY	$145.54 - $178.83 $523,944 - $643,788	3,600 New	3,600 $624,000
Q2 2023 Aug 14, 2023	SELL	$160.94 - $186.23 $96,564 - $111,738	-600 Reduced 37.5%	1,000 $172,000
Q1 2023 May 15, 2023	SELL	$145.48 - $175.02 $1.06 Million - $1.28 Million	-7,300 Reduced 82.02%	1,600 $266,000
Q4 2022 Feb 14, 2023	BUY	$131.14 - $157.47 $1.17 Million - $1.4 Million	8,900 New	8,900 $1.3 Million
Q2 2022 Aug 15, 2022	BUY	$155.97 - $200.09 $1.62 Million - $2.08 Million	10,400 New	10,400 $1.79 Million

1,961

411M

1.02M

1.09M

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $80B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.